Arginase Inhibitor in the Pharmacological Correction of Endothelial Dysfunction

This paper is about a way of correction of endothelial dysfunction with the inhibitor of arginase: L-norvaline. There is an imbalance between vasoconstriction and vasodilatation factors of endothelium on the basis of endothelial dysfunction. Among vasodilatation agents, nitrogen oxide plays the basi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pokrovskiy, Mihail V., Korokin, Mihail V., Tsepeleva, Svetlana A., Pokrovskaya, Tatyana G., Gureev, Vladimir V., Konovalova, Elena A., Gudyrev, Oleg S., Kochkarov, Vladimir I., Korokina, Liliya V., Dudina, Eleonora N., Babko, Anna V., Terehova, Elena G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124670/
https://www.ncbi.nlm.nih.gov/pubmed/21747978
http://dx.doi.org/10.4061/2011/515047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124670/
https://www.ncbi.nlm.nih.gov/pubmed/21747978
http://dx.doi.org/10.4061/2011/515047

Ejemplares similares